We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Acoustic Biosensor Assesses Feeding Safety Following Surgery

By HospiMedica International staff writers
Posted on 19 Aug 2014
A novel disposal listening device that attaches to the abdomen could help monitor digestion in postoperative patients. More...


The acoustic gastrointestinal surveillance (AGIS) device, developed by researchers at the University of California, Los Angeles (UCLA, USA), is a noninvasive biosensor resembling a small plastic cap (with a tiny microphone inside) that can detect paralytic postoperative ileus (POI), a malfunction of the intestines. Using the sensor, researchers can monitor sounds emanating from the intestines and measure the rate of acoustic events (i.e., movements) as they occur. In a study, The researchers compared intestinal rates of 7 healthy subjects by using the device for 60 minutes (after a standardized meal) to rates recorded in two postoperative groups, 8 patients who were tolerating food, and 25 that had POI.

The results showed that the AGIS separated patients from controls with 100% sensitivity and 97% specificity. According to the researchers, using the AGIS may improve surgical outcomes, decrease healthcare costs, and shorten hospital stays. The device could also be used to help diagnose irritable bowel syndrome and inflammatory bowel disease (IBD), in addition to helping obese people learn by the sounds from their gut when they should or shouldn't eat to help them lose weight. The study was published on August 5, 2104, in the Journal of Gastrointestinal Surgery.

“The way doctors currently monitor for POI is putting a stethoscope on the patient's belly for 15 seconds, briefly listening for sounds of intestinal awakening, and asking about flatulence. It's all very rudimentary and inaccurate,” said lead author Prof. Brennan Spiegel, MD. “In the future, doctors may use the biosensor to determine which patients can be fed, making an evidence-based decision instead of just guessing based on less specific information.”

“The biosensor system is… a low-cost instrument that serves an unmet need for continuous, noninvasive monitoring of the human digestive processes,” added coauthor Professor of electrical engineering William J. Kaiser, PhD, co-director of the UCLA Wireless Health Institute. “The potential for this biosensor has been thrilling, since it will serve many applications from monitoring of POI to a wide range of digestive process diagnostic applications. The biosensor can operate in the clinic, at home, and at any location on the globe.”

POI refers to obstipation and intolerance of oral intake due to nonmechanical factors that disrupt the normal coordinated propulsive motor activity of the gastrointestinal tract following abdominal or non-abdominal surgery. There is general consensus that some degree of POI is a normal obligatory and physiologic response to abdominal surgery, and is generally a benign condition that resolves without serious consequences. However, when POI is prolonged, it leads to patient discomfort, dissatisfaction, and prolonged hospitalization, and must be differentiated from mechanical bowel obstruction or other postoperative complications.

Related Links:

University of California, Los Angeles



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.